Macaque animal model for HIV-induced neurological disease

Sopper, S.; Koutsilieri, E.; Scheller, C.; Czub, S.; Riederer, P.; ter Meulen, V.
May 2002
Journal of Neural Transmission;May2002, Vol. 109 Issue 5/6, p747
Academic Journal
Summary. The pathogenesis of HIV-induced neurological disorders is still incompletely understood. Since many aspects of this disease are difficult to explore in humans, animal models are necessary to fill the gaps in our knowledge. Based on the high concordance with the human system, the SIV-infection of macaques currently provides the best animal model to study pathogenesis, therapy and prevention of HIV-infection. In this review, important features of the CNS-infection in this model are outlined. Recent virological, immunological, neurophysiological and neurochemical findings obtained with this animal model are presented and key factors in the development of neurological disease are identified.


Related Articles

  • Nonhuman primate models of NeuroAIDS. Williams, Rachel; Bokhari, Sirosh; Silverstein, Peter; Pinson, David; Kumar, Anil; Buch, Shilpa // Journal of NeuroVirology;Aug2008, Vol. 14 Issue 4, p292 

    Human Immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), also manifests neurological complications. HIV-associated dementia (HAD) is the most severe form of HIV-induced neurocognitive disorders. HIV encephalitis (HIVE), the pathological correlate of...

  • Continuous intraventricular pressure monitoring for diagnosis of normal-pressure hydrocephalus. Pfisterer, W. K.; Aboul-Enein, F.; Gebhart, E.; Graf, M.; Aichholzer, M.; Mühlbauer, M. // Acta Neurochirurgica;Oct2007, Vol. 149 Issue 10, p983 

    Objectives. Normal-pressure hydrocephalus (NPH) syndrome is treatable by implantation of a cerebrospinal fluid (CSF) shunt. However, diagnosis of NPH by clinical and radiological findings alone is unreliable, and co-existing structural dementia can contribute to low success rates after shunt...

  • Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications. Sjögren, M.; Folkesson, S.; Blennow, K.; Tarkowski, E.; Sjögren, M // Journal of Neurology, Neurosurgery & Psychiatry;Aug2004, Vol. 75 Issue 8, p1107 

    Objective: Immunological mechanisms may be part of the pathophysiological mechanisms in frontotemporal dementia (FTD), but hitherto only vague evidence of such mechanisms has been presented. The aim of this study was to compare the cerebrospinal fluid (CSF) levels of the...

  • LITERATURE MONITOR.  // Neurology Reviews;Jun2009, Vol. 17 Issue 6, p23 

    The article presents a study which measures the levels of biomakers in the cerebrospinal fluid (CSF) of patients with very mild dementia. Researchers found that the rate of dementia progression was significantly more rapid in individuals with lower baseline CSF levels. Result of the study shows...

  • Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: Preliminary observations. Berger, Joseph; Avison, Malcolm; Mootoor, Yunanan; Beach, Carol // Journal of NeuroVirology;Dec2005, Vol. 11 Issue 6, p557 

    Protein profiling using mass spectrometry may be useful in identifying previously unknown protein markers in human immunodeficiency virus (HIV) dementia and provide insight into disease pathogenesis. Six samples of matched cerebrospinal (CSF) and blood serum from patients with no, mild, and...

  • Longitudinal Analysis of nef/Long Terminal Repeat-Deleted HIV-1 in Blood and Cerebrospinal Fluid of a Long-Term Survivor Who Developed HIV-Associated Dementia. Churchill, Melissa; Sterjovski, Jasminka; Gray, Lachlan; Cowley, Daniel; Chatfield, Catherine; Learmont, Jennifer; Sullivan, John S.; Crowe, Suzanne M.; Mills, John; Brew, Bruce J.; Wesselingh, Steven L.; McPhee, Dale A.; Gorry, Paul R. // Journal of Infectious Diseases;12/15/2004, Vol. 190 Issue 12, p2181 

    We studied the evolution and compartmentalization of nefl long terminal repeat (neflLTR)-deleted human immunode- ficiency virus type I (HIV-1) from a long-term survivor who developed HIV-associated dementia (HIVD). Analysis of se- quential blood-derived HIV-1 isolated before and during HIVD...

  • HIV enters brain cells through surface receptor. Joyce, Chris // New Scientist;11/17/90, Vol. 128 Issue 1743, p27 

    Presents the findings of Yaffa Mizrachi showing that dementia in AIDS patients may come about when HIV enters brain cells through a surface receptor on the membrane of neurons and glial cells in the brain. Experimentation methods; Continuing dilemmas.

  • Guidelines for management of HIV-associated dementia, myelopathy, neuropathy and myopathy. Harrison, M. J. G.; Harrison, M J // International Journal of STD & AIDS;Jul1998, Vol. 9 Issue 7, p390 

    The article offers certain guidelines for the complexities like dementia, myelopathy, neuropathy and myopathy associated with HIV. Symptoms in HIV neuropathy, HIV myelopathy and HIV myopathy are revealed. It suggests the antiretroviral therapy in case of HIV-associated dementia, whereas, in case...

  • Aging and HIV-Related Cognitive Loss. Mateen, Farrah J.; Mills, Edward J. // JAMA: Journal of the American Medical Association;7/25/2012, Vol. 308 Issue 4, p349 

    The article comments on the prevalence of cognitive disorders related to human immunodeficiency virus (HIV) in the world. It states that among the more than several million adults living with HIV worldwide, a substantial proportion is estimated to have some form of HlV-associated neurocognitive...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics